Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Stéphane Bancel, CEO of Moderna at the Fast Company Innovation ... obsessed with ChatGPT since it was released at the end of 2022, and that his goal is for Moderna’s employees to use it no ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

Richardson: This week, in place of Journal Club, we have a very special episode featuring Stéphane Bancel, CEO of Moderna, in conversation with you, Hanne, and a16z General Partner Jorge Conde.

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

Moderna shares experienced a significant surge in trading on Thursday, posting a 5.58% gain in European markets and an impressive jump of up to 16% on the NASDAQ. This remarkable performance was ...

Stéphane Bancel discusses the company’s new Covid-19 boosters, its approach to developing vaccines for emerging variants alongside seasonal flu shots, and the use of mRNA technology to treat cancer ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases by the CEO and director. This comes as a significant ...